Click Here to return To Results

 

MATILDE Chemotherapy Regimen for Primary CNS Lymphoma Neurol 82:1370-1373, Ferreri, A.J.M.,et al, 2014 See this aricle in Pubmed Article Abstract At a median follow-up of 12 years, MATILDE regimen followed by WBRT confirmed the previously reported survival plateau, which further proves its long-lasting efficacy with acceptable neurologic deficits.

Related Tags

(click to filter results - removes previous filter) advances in neurology chemotherapy,CNS treatment and complications with efficacy lymphoma lymphoma,primary of CNS MATILDE regimen methotrexate neoplasm,primary of CNS-treatment of prognosis treatment of neurologic disorder

Click Here to return To Results